Aspinall will join the US firm in September
Ventana Medical Systems, a member of the Roche Group, has appointed Mara Aspinall as president. She will take up the role next month.
Ventana Medical Systems, based in Tucson, Arizona, is a manufacturer of instruments and reagents that automate tissue processing and slide staining for cancer diagnostics.
Aspinall was most recently founder, president, and chief executive of On-Q-ity, a start-up diagnostics company focused on circulating tumour cell technology. Prior to this, she spent 12 years with Genzyme Corporation where she held senior roles, including president of Genzyme Genetics and president of Pharmaceuticals.
‘Mara brings a track record of success at Genzyme and a wealth of diagnostics industry experience to this important role,’ said Daniel O’Day, chief operating officer, Roche Diagnostics.